Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.600
+0.010 (0.63%)
At close: Dec 19, 2025, 4:00 PM EST
1.610
+0.010 (0.63%)
After-hours: Dec 19, 2025, 7:35 PM EST
Bionano Genomics Market Cap
Bionano Genomics has a market cap or net worth of $16.28 million as of December 19, 2025. Its market cap has decreased by -33.18% in one year.
Market Cap
16.28M
Enterprise Value
11.90M
1-Year Change
-33.18%
Ranking
Category
Stock Price
$1.60
Market Cap Chart
Since September 21, 2018, Bionano Genomics's market cap has decreased from $66.34M to $16.28M, a decrease of -75.46%. That is a compound annual growth rate of -17.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 16.28M | -44.65% |
| Dec 31, 2024 | 29.41M | -59.93% |
| Dec 29, 2023 | 73.41M | -83.07% |
| Dec 30, 2022 | 433.51M | -49.86% |
| Dec 31, 2021 | 864.66M | 83.26% |
| Dec 31, 2020 | 471.81M | 1,336.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |